#tilray stock

[pavel-nosok]

Best places to buy Tilray stock: it is up after the company shook up its management team on Tuesday

Best places to buy Tilray stock: it is up after the company shook up its management team on Tuesday

Tilray stock (NASDAQ: TLRY) on Tuesday went up by 15.76% after a shook up in the management team. At close 4:00 PM EDT on Tuesday, the price was $11.66USD. Although its price has slightly dropped to a premarket price of $11.5203 at 8:08 AM EDT, experts believe that the slump of cannabis stocks might be coming to an end; something expected to buoy Tilray stock to higher prices. To help stock…

View On WordPress

[pavel-nosok]

Best places to buy Tilray stock: it is up after the company shook up its management team on Tuesday

Best places to buy Tilray stock: it is up after the company shook up its management team on Tuesday

Tilray stock (NASDAQ: TLRY) on Tuesday went up by 15.76% after a shook up in the management team. At close 4:00 PM EDT on Tuesday, the price was $11.66USD. Although its price has slightly dropped to a premarket price of $11.5203 at 8:08 AM EDT, experts believe that the slump of cannabis stocks might be coming to an end; something expected to buoy Tilray stock to higher prices. To help stock…

View On WordPress

[cannabisbusinessexecutive]

Tilray (TLRY) 3rd Quarter Earnings: What to Expect Can marijuana stocks fly high again? It’s been a rough year for the cannabis industry as doubts over legalization has caused investors to rethink interest in the sector.

[wealthyvc]

Tilray Celebrates Official Opening of European Union Campus for Medical Cannabis - The Cannabis Investor

The 250,000 square-foot facility located in Cantanhede, Portugal serves as the hub for Tilray’s cultivation, processing, distribution and research of medical cannabis products in Europe NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray (NASDAQ: TLRY), a global pioneer in the research, cultivation, production and distribution of cannabis today celebrated the official opening of its European Union (EU) Campus located in Cantanhede, Portugal. Tilray CEO Brendan Kennedy, global senior leaders and the EU Campus Team welcomed guests from all over the world including international healthcare professionals, government officials and local dignitaries to celebrate the inauguration of the company’s European production and distribution centre. For the event, which followed Tilray’s successful outdoor harvest last year and greenhouse harvest earlier this year, guests were invited to attend a ribbon-cutting ceremony and tour Tilray’s state-of-the-art facility. Tilray’s EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, as well as research labs, processing, packaging and distribution sites for medical cannabis and cannabinoid-derived medical products. To date, Tilray has invested approximately €20 million in the facility, which totals approximately 250,000 square-feet with additional room to expand. Tilray’s EU Campus also serves as a hub supporting Tilray’s clinical research and product development efforts …

+ Technical Chart and Technical Analysis Signal (Buy, Strong Buy, Neutral, Sell, Strong Sell).

Join the TCI Investor Network:

🇺🇸 USA: Text potstocks to 313131 to join

🇨🇦️ CDN: Text potstocks to 393939 to join

Subscribe to email newsletter: https://bit.ly/2Zkseth

[wealthyvc]

Tilray Announces Support for Two New Cannabis Research Studies in Canada and Australia - The Cannabis Investor

Tilray cannabis products will be used to support the Murdoch Children’s Research Institute led pilot study to evaluate the feasibility and acceptability of a randomized placebo-controlled trial of the efficacy of cannabidiol (CBD) oral solution in reducing Severe Behavioral Problems in children with Intellectual Disabilities Tilray CBD and THC capsules will be used in a study examining the safety, tolerability and effectiveness of medical cannabis on immune activation in people living with HIV being conducted by the McGill University Health Centre Tilray’s support of numerous studies conducted by leading research institutions and hospitals around the world reflects the need for more clinical data in the medical cannabis field and the Company’s commitment to advancing cannabinoid-based science to further understand the benefits it can offer to critical patient populations NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research and production, today announced its support of two new clinical studies: a pilot study led by Murdoch Children’s Research Institute (MCRI) in Melbourne, to evaluate the feasibility and acceptability of a larger randomized placebo-controlled trial of cannabis extract as a form of treatment for reducing Severe Behavioral Problems (SBP) in pediatric patients with Intellectual Disabilities (ID); and a study with McGill …

[wealthyvc]

Tilray Receives New Processing License from Health Canada - The Cannabis Investor

Newly-acquired Natura Naturals Inc. located in Leamington, Ontario obtains processing license, allowing it to produce a wide range of cannabis form factors for the Canadian market NANAIMO, British Columbia–(BUSINESS WIRE)–Natura Naturals Inc. (“Natura”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ: TLRY ) and High Park Holdings Ltd. (“High Park”), has received a standard processing license under the Cannabis Act. The Natura greenhouse facility, which previously held a standard cultivation license, will now be able to manufacture a wide range of cannabis form factors from cannabis starting material, including oil, pre-rolls, and novel formats such as topicals and edibles. Natura, which will operate under High Park Gardens Inc. (“High Park Gardens”), was acquired by Tilray in February 2019 to serve the adult-use and medical cannabis market in Canada alongside Tilray’s existing operations. The site is a 662,000 square-foot greenhouse facility with 155,000 square-feet licensed for cultivation. The addition of a standard processing license means that High Park Gardens will be able to process cannabis raw material cultivated on site – as well as raw material sourced from other cannabis licensees – into a variety of value-add product formats. This development provides Tilray’s facilities additional flexibility in the manufacture of products for the Canadian …

[wealthyvc]

Tilray Reports Successful Cannabis Harvest in Portugal and Provides Update on European Operations - The Cannabis Investor

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”) has completed a successful harvest of medical cannabis at the Company’s European Union (EU) Campus in Portugal. Tilray’s EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, as well as research labs, processing, packaging and distribution sites for medical cannabis and cannabinoid-derived medical products. To date, Tilray has invested approximately €20 million in the facility, which totals nearly 250,000 square-feet with additional room to expand. Tilray’s EU Campus also serves as a hub supporting Tilray’s clinical research and product development efforts across Europe. Tilray’s EU Campus currently employs 100 people, and that number is expected to double by the end of 2019, with production ramping up and multiple harvests anticipated in the coming months. “Our harvest in Portugal is an exciting milestone for the company as we continue to build our multinational supply chain of high-quality medical cannabis,” said Sascha Mielcarek, Managing Director, Europe. “We look forward to utilizing the capacity of Tilray Portugal to supply the medical cannabis …